| 期 |
标题 |
文件 |
| 卷 31, 编号 8 (2024) |
Research Progress in Small Molecules as Anti-vitiligo Agents |
(Eng)
|
|
Wu H., Niu C., Aisa H.
|
| 卷 31, 编号 9 (2024) |
Research Progress in the Clinical Treatment of Familial Hypercholesterolemia |
(Eng)
|
|
Ai J., Zhao P., Zhang W., Rao G.
|
| 卷 31, 编号 21 (2024) |
Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy |
(Eng)
|
|
Lai C., Lin S., Liu W., Jin Y.
|
| 卷 31, 编号 40 (2024) |
Research Progress of Pyroptosis in Renal Diseases |
(Eng)
|
|
Hu B., Ma K., Wang W., Han Z., Chi M., Nasser M., Liu C.
|
| 卷 31, 编号 1 (2024) |
Research Progress on Antiviral Activity of Heparin |
(Eng)
|
|
Wang Y., Zhang Y., Wang P., Jing T., Hu Y., Chen X.
|
| 卷 31, 编号 4 (2024) |
Research Status, Synthesis and Clinical Application of Antiepileptic Drugs |
(Eng)
|
|
Wang S., Zhao M., Zhao P., Zhang W., Rao G.
|
| 卷 31, 编号 15 (2024) |
Resveratrol Inhibits Hepatocellular Carcinoma Progression through Regulating Exosome Secretion |
(Eng)
|
|
Tong K., Wang P., Li Y., Tong Y., li X., Yan S., Hu P.
|
| 卷 31, 编号 2 (2024) |
Resveratrol Inhibits Restenosis through Suppressing Proliferation, Migration and Trans-differentiation of Vascular Adventitia Fibroblasts via Activating SIRT1 |
(Eng)
|
|
Li M., Luo L., Xiong Y., Wang F., Xia Y., Zhang Z., Ke J.
|
| 卷 31, 编号 15 (2024) |
Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma |
(Eng)
|
|
Kozyra P., Pitucha M.
|
| 卷 31, 编号 40 (2024) |
Rhodotorulic Acid and its Derivatives: Synthesis, Properties, and Applications |
(Eng)
|
|
Stefaniak J., Nowak M., Skwarecki A.
|
| 卷 31, 编号 41 (2024) |
Rituximab Combined with Steroid and Tacrolimus Treats Proliferative Glomerulonephritis with Monoclonal IgG Deposits: A Case Report and Review of the Literature |
(Eng)
|
|
Liu D., Xia M., Wang C., Zhu X., Chen G., Liu H.
|
| 卷 31, 编号 29 (2024) |
Role of Circular RNAs in Prostate Cancer |
(Eng)
|
|
Chen F., Zhang F., Liu Y., Leng Y.
|
| 卷 31, 编号 13 (2024) |
Role of LncRNA MIAT in Diabetic Complications |
(Eng)
|
|
Wang L., Wang H., Luo Y., Wu W., Gui Y., Zhao J., Xiong R., Li X., Yuan D., Yuan C.
|
| 卷 31, 编号 34 (2024) |
Role of S100 and YKL40 on Intraventricular Cerebral Hemorrhages in the Preterm Infant and the Neuroprotective Role of miR-138- siRNAs-HIF-1a and miR-21-siRNAs-HVCN1 in Neonatal Mice with Nerve Injury |
(Eng)
|
|
Ijabi R., Kaminsky Z., Roozehdar P., Ijabi J., Moradi-Sardareh H., Tehranian N.
|
| 卷 31, 编号 39 (2024) |
Roles of PCSK9 in the Pathogenesis of Periodontal Disease |
(Eng)
|
|
Khosrojerdi M., Reiner ., Vatanparast N., Jamialahmadi T., Kesharwani P., Sahebkar A.
|
| 卷 31, 编号 20 (2024) |
Screening and Activity Evaluation of Novel BCR-ABL/T315I Tyrosine Kinase Inhibitors |
(Eng)
|
|
Su J., Fu C., Wang S., Chen X., Wang R., Shi H., Li J., Wang X.
|
| 卷 31, 编号 27 (2024) |
Selective Activation of G Protein-coupled Estrogen Receptor 1 Attenuates Atherosclerosis |
(Eng)
|
|
Haider M., Sahebkar A., Eid A.
|
| 卷 31, 编号 15 (2024) |
Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer |
(Eng)
|
|
Xu Y., Shen Y., Bhandari A., Hirachan S., Wang O., Xia E.
|
| 卷 31, 编号 21 (2024) |
SETD1A-mediated Methylation of H3K4me3 Inhibits Ferroptosis in Non-small Cell Lung Cancer by Regulating the WTAPP1/WTAP Axis |
(Eng)
|
|
Wang D., Zu Y., Sun W., Fan X.
|
| 卷 31, 编号 26 (2024) |
Severity of COVID-19 in Pregnant Women: A Review on the Potential Role of Regulatory T Cells |
(Eng)
|
|
Saghafi N., Mahmoudi M., Momtazi-Borojeni A., Mirzaeian S., Tavasolian F., Sathyapalan T., Abdollahi E., Sahebkar A.
|
| 卷 31, 编号 30 (2024) |
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus |
(Eng)
|
|
Lukic N., Macvanin M., Gluvic Z., Rizzo M., Radak D., Suri J., Isenovic E.
|
| 卷 31, 编号 10 (2024) |
Simple Synthesis of [18F] AV-45 and its Clinical Application in the Diagnosis of Alzheimer's Disease |
(Eng)
|
|
Zhang Q., Yilihamu N., Li Y., Li X., Qin Y.
|
| 卷 31, 编号 42 (2024) |
Single-cell RNA Sequencing Analysis Reveals the Role of Cancerassociated Fibroblasts in Skin Melanoma |
(Eng)
|
|
Lian W., Xiang P., Ye C., Xiong J.
|
| 卷 31, 编号 12 (2024) |
Single-cell Sequencing Data Reveals Aggressive CD68-type Macrophages and Prognostic Models in Bladder Cancer |
(Eng)
|
|
Mao C., Xu N.
|
| 卷 31, 编号 11 (2024) |
Sleep, Dietary Melatonin Supplementation, and COVID-19 |
(Eng)
|
|
Gasmi A., Semenova Y., Noor S., Benahmed A., Bjørklund G.
|
| 卷 31, 编号 27 (2024) |
Small Molecule Inhibitors against the Bacterial Pathogen Brucella |
(Eng)
|
|
Wu Y., Guo Y., Ma Y., Yu H., Wang Z.
|
| 卷 31, 编号 33 (2024) |
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021 |
(Eng)
|
|
Duncan C., Gunosewoyo H., Mocerino M., Payne A.
|
| 卷 31, 编号 12 (2024) |
Spinal Muscular Atrophy Treatment: The MTOR Regulatory Intervention |
(Eng)
|
|
Lashgari N., Roudsari N., Shayan M., Eshraghi S., Momtaz S., Jamialahmadi T., Abdolghaffari A., Sahebkar A.
|
| 卷 31, 编号 15 (2024) |
State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis |
(Eng)
|
|
Francesconi V., Rizzo M., Schenone S., Carbone A., Tonelli M.
|
| 卷 31, 编号 40 (2024) |
Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy |
(Eng)
|
|
Hale Alkan A., Ensoy M., Cansaran-Duman D.
|
| 卷 31, 编号 11 (2024) |
Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists |
(Eng)
|
|
Ghafir El Idrissi I., Podlewska S., Abate C., Bojarski A., Lacivita E., Leopoldo M.
|
| 卷 31, 编号 5 (2024) |
Structure-based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Metabolic Reactivity Studies of Quinazoline Derivatives for their Anti-EGFR Activity Against Tumor Angiogenesis |
(Eng)
|
|
Shah A., Ahmad S., Yadav M., Raza K., Kamal M., Akhtar S.
|
| 卷 31, 编号 40 (2024) |
Synthesis and Anti-bacterial Activity of New Substituted 2-trifluoromethyl-4-quinolinylhydrazone Analogs against Mycobacterium tuberculosis Strains |
(Eng)
|
|
da Silva E., de Andrade G., Lourenço M., De Souza M.
|
| 卷 31, 编号 24 (2024) |
Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors |
(Eng)
|
|
Olgen S., Kaleli S., Karaca B., Demirel U., Bristow H.
|
| 卷 31, 编号 39 (2024) |
Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds |
(Eng)
|
|
Nian C., Gan X., Liu Q., Wu Y., Kong M., Zhang P., Jin M., Dong Z., Li W., Wang L., He W., Li X., Wu J.
|
| 卷 31, 编号 25 (2024) |
Synthesis and Biological Evaluations of Granulatamide B and its Structural Analogues |
(Eng)
|
|
Matulja D., Grbčić P., Matijević G., Babić S., Bojanić K., Laclef S., Vrček V., Čo-Rakovac R., Pavelić S., Marković D.
|
| 卷 31, 编号 15 (2024) |
Synthesis and Selective Anticancer Activity Evaluation of 2-phenylacrylonitrile Derivatives as Tubulin Inhibitors |
(Eng)
|
|
Jin Y., Xin Y., Li Y., Chen X., Man D., Tian Y.
|
| 卷 31, 编号 38 (2024) |
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site Inhibitors |
(Eng)
|
|
Shihab W., Kubba A., Tahtamouni L., Saleh K., AlSakhen M., Kanaan S., Saleh A., Yasin S.
|
| 卷 31, 编号 22 (2024) |
Synthesis of β-Amino Carbonyl 6-(Aminomethyl)- and 6-(Hydroxymethyl)pyrazolopyrimidines for DPP-4 Inhibition Study |
(Eng)
|
|
Chung C., Tseng C., Li S., Zeng W., Lin Y., Hu Y., Jiang W., Huang G., Tsai H., Wong F.
|
| 卷 31, 编号 17 (2024) |
Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer |
(Eng)
|
|
Wang C., Chen Y., Zhou R., Yang Y., Fang Y.
|
| 卷 31, 编号 32 (2024) |
Targeting Cervical Cancer Stem Cells by Phytochemicals |
(Eng)
|
|
Tripathi T., Yadav J., Janjua D., Chaudhary A., Joshi U., Senrung A., Chhokar A., Aggarwal N., Bharti A.
|
| 卷 31, 编号 16 (2024) |
Targeting Cysteine and Serine Proteases to Discover New Drugs Against Neglected Tropical Diseases |
(Eng)
|
|
dos Santos Nascimento I., de Moura R.
|
| 卷 31, 编号 16 (2024) |
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis |
(Eng)
|
|
Saha A., Pushpa ., Moitra S., Basak D., Brahma S., Mondal D., Molla S., Samadder A., Nandi S.
|
| 卷 31, 编号 15 (2024) |
Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors |
(Eng)
|
|
Lou S., Wu M., Cui S.
|
| 卷 31, 编号 16 (2024) |
Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs |
(Eng)
|
|
dos Santos Nascimento I., Albino S., da Silva Menezes K., de Azevedo Teotônio Cavalcanti M., de Oliveira M., Mali S., de Moura R.
|
| 卷 31, 编号 20 (2024) |
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors |
(Eng)
|
|
Du S., Fang Y., Zhang W., Rao G.
|
| 卷 31, 编号 27 (2024) |
The Application of Graphene Oxide Nanoarchitectures in the Treatment of Cancer: Phototherapy, Immunotherapy, and the Development of Vaccines |
(Eng)
|
|
Bhattacharya S., Belemkar S., Prajapati B.
|
| 卷 31, 编号 20 (2024) |
The Applications of Molecular Dynamics Simulation in Studying Protein Structure and Dynamics |
(Eng)
|
|
Guo J., Liu H.
|
| 卷 31, 编号 39 (2024) |
The Association between High-density Lipoproteins and Periodontitis |
(Eng)
|
|
Ehteshami A., Shirban F., Bagherniya M., Sathyapalan T., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 42 (2024) |
The Beneficial Effects of Curcumin on Lipids: Possible Effects on Dyslipidemia-induced Cardiovascular Complications |
(Eng)
|
|
Yaribeygi H., Maleki M., Butler A., Jamialahmadi T., Gumpricht E., Sahebkar A.
|
| 卷 31, 编号 23 (2024) |
The Chemoprotective Potentials of Alpha-lipoic Acid against Cisplatin-induced Ototoxicity: A Systematic Review |
(Eng)
|
|
Zabibah R., Gupta J., Iqbal M., Iswanto A., Farhood B., Lateef Al-Awsi G., Arshed U., Arif A., Ramírez-Coronel A., Alhassan M., Mustafa Y., Rahman F.
|
| 卷 31, 编号 28 (2024) |
The Combined Effect of Curcumin and Crocin on the Reduction of Inflammatory Responses in Arthritic Rats |
(Eng)
|
|
Rashidi K., Korani M., Nemati H., Shahraki R., Korani S., Abbasifard M., Majeed M., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 19 (2024) |
The Development of Non-natural Type Nucleoside to Stabilize Triplex DNA Formation against CG and TA Inversion Site |
(Eng)
|
|
Wang L., Ling Y., Tian Y., Wang X., Sasaki S., Taniguchi Y.
|
| 卷 31, 编号 20 (2024) |
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists |
(Eng)
|
|
Fang H., Niu B., Chen Q.
|
| 卷 31, 编号 13 (2024) |
The Effect of Statin Therapy on Serum Uric Acid Levels: A Systematic Review and Meta-analysis |
(Eng)
|
|
Akbari A., Razmi M., Rafiee M., Watts G., Sahebkar A.
|
| 卷 31, 编号 11 (2024) |
The Effect of Statins on the Differentiation and Function of Central Nervous System Cells |
(Eng)
|
|
Chamani S., Mobasheri L., Zerehpoosh S., Naghizadeh A., McCloskey A., Rizzo M., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 36 (2024) |
The Effects of Curcumin on Brain-Derived Neurotrophic Factor Expression in Neurodegenerative Disorders |
(Eng)
|
|
Radbakhsh S., Butler A., Moallem S., Sahebkar A.
|
| 卷 31, 编号 5 (2024) |
The Efficient Activity of Glabridin and its Derivatives Against EGFRmediated Inhibition of Breast Cancer |
(Eng)
|
|
Ghosh A., Ghosh D., Mukerjee N., Maitra S., Das P., Dey A., Sharkawi S., Zouganelis G., Alexiou A., Chaudhari S., Sharma R., Waghmare S., Papadakis M., Batiha G.
|
| 卷 31, 编号 29 (2024) |
The Epigenetic Contribution to the Pathogenesis of Psoriasis: Recent Advances |
(Eng)
|
|
Aslani S., Mirarefin S., Zarredar H., Asadi M., Javan M., Khosrojerdi A., Johnston T., Sahebkar A.
|
| 卷 31, 编号 20 (2024) |
The Function of Autophagy in the Initiation, and Development of Breast Cancer |
(Eng)
|
|
Beilankouhi E., Valilo M., Dastmalchi N., Teimourian S., Safaralizadeh R.
|
| 卷 31, 编号 36 (2024) |
The Impact of Alcohol-Induced Epigenetic Modifications in the Treatment of Alcohol use Disorders |
(Eng)
|
|
Fanfarillo F., Ferraguti G., Lucarelli M., Fuso A., Ceccanti M., Terracina S., Micangeli G., Tarani L., Fiore M.
|
| 卷 31, 编号 9 (2024) |
The Impact of lncRNA-GAS5/miRNA-200/ACE2 Molecular Pathway on the Severity of COVID-19 |
(Eng)
|
|
Ayeldeen G., Shaker O., Amer E., Zaafan M., Herzalla M., Keshk M., Abdelhamid A.
|
| 卷 31, 编号 18 (2024) |
The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases |
(Eng)
|
|
Rizzo M.
|
| 卷 31, 编号 2 (2024) |
The Importance of Nanocarriers Intra- and Extracellular Degradation: What we Know and Should Know About it? |
(Eng)
|
|
Parodi A., Voronina M., Zamyatnin A.
|
| 卷 31, 编号 42 (2024) |
The Link between miRNAs and PCKS9 in Atherosclerosis |
(Eng)
|
|
Macvanin M., Gluvic Z., Klisic A., Manojlovic M., Suri J., Rizzo M., Isenovic E.
|
| 卷 31, 编号 35 (2024) |
The Mechanisms of miRNAs on Target Regulation and their Recent Advances in Atherosclerosis |
(Eng)
|
|
Yin R., Lu H., Cao Y., Zhang J., Liu G., Guo Q., Kai X., Zhao J., Wei Y.
|
| 卷 31, 编号 33 (2024) |
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection |
(Eng)
|
|
Gupta J., Jalil A., Abd Alzahraa Z., Aminov Z., Alsaikhan F., Ramírez-Coronel A., Ramaiah P., Najafi M.
|
| 卷 31, 编号 34 (2024) |
The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole, Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS |
(Eng)
|
|
Xia M., Liu Y., Chen J., Xu R., Dai G.
|
| 卷 31, 编号 32 (2024) |
The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review |
(Eng)
|
|
Chaudhuri R., Samanta A., Saha P., Ghosh S., Sinha D.
|
| 卷 31, 编号 14 (2024) |
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy |
(Eng)
|
|
Cui Y., Zhang J., Zhang G.
|
| 卷 31, 编号 35 (2024) |
The Potential Therapeutic Applications of CRISPR/Cas9 in Colorectal Cancer |
(Eng)
|
|
Pourali G., Maftooh M., Akbarzade H., Hassanian S., Mobarhan M., Ferns G., Khazaei M., Avan A., Sahranavard T., Mehrabadi S.
|
| 卷 31, 编号 35 (2024) |
The Protective Effects of Curcumin against Renal Toxicity |
(Eng)
|
|
Zhai J., Chen Z., Zhu Q., Guo Z., Wang N., Zhang C., Deng H., Wang S., Yang G.
|
| 卷 31, 编号 42 (2024) |
The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review |
(Eng)
|
|
Gupta J., Jalil A., Riyad Muedii Z., Aminov Z., Alsaikhan F., Ramírez-Coronel A., Ramaiah P., Farhood B.
|
| 卷 31, 编号 37 (2024) |
The Role of the Vagus Nerve in the Microbiome and Digestive System in Relation to Epilepsy |
(Eng)
|
|
Rubio C., Ochoa E., Gatica F., Portilla A., Vázquez D., Rubio-Osornio M.
|
| 卷 31, 编号 39 (2024) |
The Roles of Endogenous D2R Dopamine and µ-opioid Receptors of the Brain in Alcohol use Disorder |
(Eng)
|
|
Khikhmetova K., Semenova Y., Bjørklund G.
|
| 卷 31, 编号 12 (2024) |
The Structure-property Relationships of Clinically Approved Protease Inhibitors |
(Eng)
|
|
Choi K.
|
| 卷 31, 编号 35 (2024) |
The Tao of Copper Metabolism: From Physiology to Pathology |
(Eng)
|
|
Gao S., Zhou M., Tang Z.
|
| 卷 31, 编号 18 (2024) |
The Therapeutic Effect of Natural Compounds on Osteoporosis through Ferroptosis |
(Eng)
|
|
Zhang Y., Qu Z., Zhao Y., Zhang B., Gong Y., Wang X., Gao X., Wang D., Yan L.
|
| 卷 31, 编号 21 (2024) |
The Treatment of a New Entity in Advanced Non-small Cell Lung Cancer: MET Exon 14 Skipping Mutation |
(Eng)
|
|
Rocco D., Gravara L., Palazzolo G., Gridelli C.
|
| 卷 31, 编号 39 (2024) |
The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer |
(Eng)
|
|
Martín-García D., Téllez T., Redondo M., García-Aranda M.
|
| 卷 31, 编号 3 (2024) |
Therapeutic and Diagnostic Agents based on Bioactive Endogenous and Exogenous Coordination Compounds |
(Eng)
|
|
Kostova I.
|
| 卷 31, 编号 27 (2024) |
Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways |
(Eng)
|
|
Poortalebi H., ZareDini M., Foroughi-Nematollahi S., Farkhondeh T., Samarghandian S., Pourhanifeh M.
|
| 卷 31, 编号 21 (2024) |
Therapeutic Effects of Statins: Promising Drug for Topical and Transdermal Administration |
(Eng)
|
|
Zahedipour F., Hosseini S., Reiner ., Tedeschi-Reiner E., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 15 (2024) |
Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus |
(Eng)
|
|
Kamal S., Shahzad A., Rehman K., Tariq K., Akash M., Imran M., Assiri M.
|
| 卷 31, 编号 25 (2024) |
Therapeutic Potential of Decoys for Prostate Cancers: A Review of Recent Updates |
(Eng)
|
|
Rezaei S., Mahjoubin-Tehran M., Iratni R., Sahebkar A.
|
| 卷 31, 编号 27 (2024) |
Therapeutic Potential of Iron Chelators in Viral Diseases: A Systematic Review |
(Eng)
|
|
Lori M., Khandani A., Dehghannoudeh G., Ohadi M., Ansari M.
|
| 卷 31, 编号 29 (2024) |
Therapeutical Approach to Arterial Hypertension - Current State of the Art |
(Eng)
|
|
Radosavljevic M., Vučević D., Samardić J., Radenkovic M., Radosavljević T.
|
| 卷 31, 编号 20 (2024) |
Thiazole, Isatin and Phthalimide Derivatives Tested in vivo against Cancer Models: A Literature Review of the Last Six Years |
(Eng)
|
|
Pinto A., Nunes J., Severino Martins J., Leal A., Silva C., da Silva A., da Cruz Olímpio D., da Silva E., Campos T., Lima Leite A.
|
| 卷 31, 编号 16 (2024) |
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next? |
(Eng)
|
|
González J., Salas-Sarduy E., Alvarez L., Valiente P., Arni R., Pascutti P.
|
| 卷 31, 编号 24 (2024) |
To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds |
(Eng)
|
|
Bhattacharjee B., Chakrovorty A., Biswas M., Samadder A., Nandi S.
|
| 卷 31, 编号 21 (2024) |
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19 |
(Eng)
|
|
Gasmi A., Tippairote T., Mujawdiya P., Menzel A., Lysiuk R., Shanaida M., Lenchyk L., Peana M., Bjørklund G.
|
| 卷 31, 编号 28 (2024) |
Treatment of MRSA Infection: Where are We? |
(Eng)
|
|
Nazli A., Tao W., You H., He X., He Y.
|
| 卷 31, 编号 14 (2024) |
Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects |
(Eng)
|
|
Abdelkhalek A., Attia M., Kamal M.
|
| 卷 31, 编号 30 (2024) |
TRIM65 Suppresses oxLDL-induced Endothelial Inflammation by Interaction with VCAM-1 in Atherogenesis |
(Eng)
|
|
Ma X., Zhou Y., Zhou Z., Liu H., Zhou B., Deng N., Zhou K., Tian Z., Wu Z., Liu X., Fu M., Jiang Z.
|
| 卷 31, 编号 22 (2024) |
TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells |
(Eng)
|
|
Liu G., Wang H., Ran R., Wang Y., Li Y.
|
| 卷 31, 编号 3 (2024) |
Type 2 Diabetes and HDL Dysfunction: A Key Contributor to Glycemic Control |
(Eng)
|
|
Rotllan N., Julve J., Escolà-Gil J.
|
| 卷 31, 编号 14 (2024) |
Unlocking the Benefits of Fasting: A Review of its Impact on Various Biological Systems and Human Health |
(Eng)
|
|
Mackieh R., Al-Bakkar N., Kfoury M., Okdeh N., Pietra H., Roufayel R., Legros C., Fajloun Z., Sabatier J.
|
| 卷 31, 编号 36 (2024) |
Unlocking the Immunomodulatory Potential of Rosmarinic Acid Isolated from Punica granatum L. using Bioactivity-Guided Approach: In Silico, In Vitro, and In Vivo Approaches |
(Eng)
|
|
Gautam R., Tripathi S., Akash S., Sharma S., Sharma K., Goyal S., Behzad S., Gundamaraju R., Mishra D., Zhang Y., Shen B., Sundriyal S., Singla R.
|
| 卷 31, 编号 41 (2024) |
Urinary miRNAs and Prostate Cancer: Is there a Crossover Point Eventually, and where should we Head? |
(Eng)
|
|
Giannakodimos I.
|
| 卷 31, 编号 7 (2024) |
Zingiber officinale Roscoe (Ginger) and its Bioactive Compounds in Diabetes: A Systematic Review of Clinical Studies and Insight of Mechanism of Action |
(Eng)
|
|
Van B., Abdalla A., Algarni A., Khalid A., Zengin G., Aumeeruddy M., Mahomoodally M.
|
| 301 - 400 的 400 信息 |
<< < 1 2 3 4 |
